10.00
-2.00
(-16.67%)
As of January 30 at 12:33:38 PM EST. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
1,409.62
1,536.05
1,776.65
1,990.87
1,812.14
Operating Income
-1,409.62
-1,536.05
-1,776.65
-1,990.87
-1,812.14
Net Non Operating Interest Income Expense
-573.79
-665.78
-532.79
-563.19
-449.46
Other Income Expense
30.31
252.17
-480.98
-159.01
122.24
Pretax Income
-1,953.10
-1,949.66
-2,790.41
-2,713.06
-2,139.36
Tax Provision
-129.13
-129.13
-129.84
-54.98
-113.42
Net Income Common Stockholders
-1,874.36
-2,013.49
-3,126.84
-3,358.43
-2,417.70
Diluted NI Available to Com Stockholders
-1,874.36
-2,013.49
-3,126.84
-3,358.43
-2,417.70
Basic EPS
0.30
-0.02
-1.80
-49.23
-800.00
Diluted EPS
0.30
-0.02
-1.80
-49.23
-800.00
Basic Average Shares
103,168.71
85,045.34
1,738.80
68.22
3.03
Diluted Average Shares
103,168.71
85,045.34
1,738.80
68.22
3.03
Total Operating Income as Reported
-1,409.62
-1,536.05
-1,776.65
-1,990.87
-1,812.14
Rent Expense Supplemental
35.32
34.15
28.84
28.37
28.11
Total Expenses
1,409.62
1,536.05
1,776.65
1,990.87
1,812.14
Net Income from Continuing & Discontinued Operation
-1,823.97
-1,820.53
-2,660.57
-2,658.09
-2,025.95
Normalized Income
-1,852.28
-2,056.00
-2,201.97
-2,502.30
-2,141.70
Interest Income
0.04
0.06
0.04
5.61
0.00
Interest Expense
573.84
665.84
532.82
568.80
449.46
Net Interest Income
-573.79
-665.78
-532.79
-563.19
-449.46
EBIT
-1,379.27
-1,283.82
-2,257.59
-2,144.27
-1,689.91
EBITDA
-1,357.34
-1,262.16
-2,234.66
-2,138.60
-1,687.91
Reconciled Depreciation
21.93
21.66
22.93
5.67
1.99
Net Income from Continuing Operation Net Minority Interest
-1,823.97
-1,820.53
-2,660.57
-2,658.09
-2,025.95
Total Unusual Items Excluding Goodwill
30.31
252.17
-480.98
-159.01
122.24
Total Unusual Items
30.31
252.17
-480.98
-159.01
122.24
Normalized EBITDA
-1,387.65
-1,514.33
-1,753.68
-1,979.59
-1,810.15
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
2.00
16.70
-22.38
-3.22
6.48
6/30/2021 - 1/7/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYMX Mymetics Corporation
0.0010
0.00%
EMMA Emmaus Life Sciences, Inc.
0.0163
0.00%
PKTX ProtoKinetix, Incorporated
0.0095
-5.00%
GSTC GlobeStar Therapeutics Corporation
0.0003
0.00%
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0014
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0011
0.00%
EPRX Eupraxia Pharmaceuticals Inc.
2.8957
-3.48%
AXIM AXIM Biotechnologies, Inc.
0.0040
0.00%
TXTM ProText Mobility, Inc.
0.0009
0.00%
PVCT Provectus Biopharmaceuticals, Inc.
0.1071
-2.64%